Literature DB >> 2635924

Surgical treatment of thoracic hydatidosis. A review of 100 cases.

J Zapatero1, L Madrigal, J Lago, B Baschwitz, E Pérez, J Candelas.   

Abstract

Hydatid cystic disease continues to hold an important place in chest disease in our country. The authors review their experience from 1977 to 1987 of 100 patients who underwent surgery for pulmonary hydatidosis. Mean age was 36.21 years. Fifty-nine cases were ruptured cysts (RC) and 41 were unruptured cysts (UC). The diagnosis was based on epidemiological, radiological and mainly serological and endoscopic criteria. The indirect haemagglutination test was positive in 100% of RC and 80% of UC, while 70.2% of the patients who underwent fiberoptic bronchoscopy showed pathological changes. The most commonly used surgical procedure in UC was open subtotal cystopericystectomy (89.09%), while wedge resection (41.81%) was the most commonly used technique for the RC. There were no operative deaths and no recurrences were observed for a mean follow-up of 5.4 years. The indications for adjuvant chemotherapy with mebendazole are presented.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2635924     DOI: 10.1016/1010-7940(89)90054-7

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  4 in total

Review 1.  Immunodiagnosis of human hydatid disease: Where do we stand?

Authors:  Bahador Sarkari; Zahra Rezaei
Journal:  World J Methodol       Date:  2015-12-26

2.  Pulmonary cystic hydatid disease in Ireland.

Authors:  M W Butler; R H Mullan; K E Schaffer; T B Crotty; D A Luke; S C Donnelly
Journal:  Ir J Med Sci       Date:  2003 Oct-Dec       Impact factor: 1.568

3.  Seronegative, complicated hydatid cyst of the lung: A case report.

Authors:  Eva Letty Susanne Engström; Goran Nadir Salih; Lothar Wiese
Journal:  Respir Med Case Rep       Date:  2017-04-10

4.  Rare Cause of Tension Pneumothorax: Hydatid Disease of Lung: A Case Report.

Authors:  Achyut Bhakta Acharya; Narendra Bhatta; Deebya Raj Mishra; Avatar Verma; Rejina Shahi
Journal:  JNMA J Nepal Med Assoc       Date:  2020-04-30       Impact factor: 0.406

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.